TIMP1 and neoplasm: We further demonstrated that both T cells and DCs secrete TIMP-1 and that its soluble form increased the expression of MHC-I in myeloid DCs, exposed to tumor antigens, highlighting its potential to enhance antigen presentation in DCs, particularly in classical type 1 dendritic cells (cDC1).